01Mar

March 2017

Posted by Barny Avocats, in Workflow

Cabinet Barny advised Neurochlore on the conclusion of an exclusive license agreement with Servier for the development and commercialization of bumetanide in the field of autism in children in Europe.

Logo - Barny Avocats
52, avenue des Vosges
67000 Strasbourg

Tél. +33 (0)3 88 36 34 39
Fax. +33 (0)3 88 35 24 71